DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13396
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTaliyan, Rajeev-
dc.date.accessioned2023-12-13T08:50:41Z-
dc.date.available2023-12-13T08:50:41Z-
dc.date.issued2022-
dc.identifier.urihttps://www.sciencedirect.com/science/article/abs/pii/B9780128207574000168-
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13396-
dc.description.abstractMultiple biological barriers and discrepancy in releasing the optimal dosage range pose a great challenge in the current therapeutic management for majority of diseases. Nanoparticle drug delivery system (5–250 nm) possesses the capacity to overcome such difficulties making it an incredible choice for disease management. Various types of nanoparticles are readily available in the market each possessing its own unique characteristics, however, based on their size, shape, and surface reactivity, they can inflict certain type of toxicity, the most common being biological toxicity to human tissue and to cell culture. The toxicity can further lead to an enhanced level of oxidative stress and inflammatory cytokine. Hence, in the following chapter, we discuss the various types of nanoparticles available, its importance in the clinical field and a detailed understanding on the biological toxicity of nanoparticles.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectPharmacyen_US
dc.subjectNanoparticle drug delivery systemen_US
dc.titleBiological toxicity of nanoparticlesen_US
dc.typeArticleen_US
Appears in Collections:Department of Pharmacy

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.